Determinants of Propranolol’s Selective Effect on Loss Aversion

Psychological Science

Volumn 26, Issue 7, 2015, Pages 1123-1130

  Sokol Hessner, Peter ^a   Lackovic, Sandra F ^a   Tobe, Russell H ^b   Camerer, Colin F ^c   Leventhal, Bennett L ^b,d   Phelps, Elizabeth A ^a,b  

^a NEW YORK UNIVERSITY   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^c CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

decision making; emotion; loss aversion; open data; propranolol; risk attitudes

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROPRANOLOL;

ADULT; AFFECT; AROUSAL; CONTROLLED STUDY; DECISION MAKING; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; FEMALE; HIGH RISK BEHAVIOR; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; YOUNG ADULT;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AFFECT; AROUSAL; CHOICE BEHAVIOR; DECISION MAKING; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LINEAR MODELS; MALE; PROPRANOLOL; RISK-TAKING; YOUNG ADULT;

EID: 84937019972     PISSN: 09567976     EISSN: 14679280     Source Type: Journal    
DOI: 10.1177/0956797615582026     Document Type: Article

References (25)

1. A.BecharaH.DamasioD.TranelA.R.Damasio (1997). Deciding advantageously before knowing the advantageous strategy. Science, 275, 1293–1295. doi:10.1126/science.275.5304.1293
2. L.BorgströmC.-G.JohanssonH.LarssonR.Lenander (1981). Pharmacokinetics of propranolol. Journal of Pharmacokinetics & Biopharmaceutics, 9, 419–429.
3. S.BowmanS.HudsonG.SimpsonJ.MunroJ.Clements (1986). A comparison of the pharmacokinetics of propranolol in obese and normal volunteers. British Journal of Clinical Pharmacology, 21, 529–532.
4. B.De MartinoC.F.CamererR.Adolphs (2010). Amygdala damage eliminates monetary loss aversion. Proceedings of the National Academy of Sciences, USA, 107, 3788–3792.
5. B.DunnH.GaltonR.MorganD.EvansC.OliverM.MeyerT.. Dalgleish (2010). Listening to your heart: How interoception shapes emotion experience and intuitive decision making. Psychological Science, 21, 1835–1844. doi:10.1177/0956797610389191
6. H.GaravanJ.C.PendergrassT.J.RossE.A.SteinR.C.Risinger (2001). Amygdala response to both positively and negatively valenced stimuli. NeuroReport, 12, 2779–2783.
7. J.GlascherR.Adolphs (2003). Processing of the arousal of subliminal and supraliminal emotional stimuli by the human amygdala. The Journal of Neuroscience, 23, 10274–10282.
8. J.E.LeDoux (2000). Emotion circuits in the brain. Annual Review of Neuroscience, 23, 155–184.
9. J.S.LernerD.Keltner (2001). Fear, anger, and risk. Journal of Personality and Social Psychology, 81, 146–159.
10. A.W.LoD.V.Repin (2002). The psychophysiology of real-time financial risk processing. Journal of Cognitive Neuroscience, 14, 323–339. doi:10.1162/089892902317361877
11. J.L.McGaugh (2002). Amygdala modulation of memory consolidation: Interaction with other brain systems. Neurobiology of Learning and Memory, 78, 539–552.
12. J.L.McGaugh (2004). The amygdala modulates the consolidation of memories of emotionally arousing experiences. Annual Review of Neuroscience, 27, 1–28.
13. E.A.PhelpsK.M.LempertP.Sokol-Hessner (2014). Emotion and decision making: Multiple modulatory neural circuits. Annual Review of Neuroscience, 37, 263–287.
14. A.J.PorcelliM.R.Delgado (2009). Acute stress modulates risk taking in financial decision making. Psychological Science, 20, 278–283.
15. R.D.RogersM.LancasterJ.WakeleyZ.Bhagwagar (2004). Effects of beta-adrenoceptor blockade on components of human decision-making. Psychopharmacology, 172, 157–164.
16. K.R.Scherer (2005). What are emotions? And how can they be measured?Social Science Information, 44, 695–729. doi:10.1177/0539018405058216
17. P.Sokol-HessnerC.F.CamererE.A.Phelps (2013). Emotion regulation reduces loss aversion and decreases amygdala responses to losses. Social Cognitive and Affective Neuroscience, 8, 341–350. doi:10.1093/scan/nss002
18. P.Sokol-HessnerC.A.HartleyJ.R.HamiltonE.A.Phelps (2015). Interoceptive ability predicts aversion to losses. Cognition & Emotion, 29, 695–701. doi:10.1080/02699931.2014.925426
19. P.Sokol-HessnerM.HsuN.G.CurleyM.R.DelgadoC.F.CamererE.A.Phelps (2009). Thinking like a trader selectively reduces individuals’ loss aversion. Proceedings of the National Academy of Sciences, USA, 106, 5035–5040. doi:10.1073/pnas.0806761106
20. H.TakahashiS.FujieC.F.CamererR.ArakawaH.TakanoF.KodakaT.. Suhara (2013). Norepinephrine in the brain is associated with aversion to financial loss. Molecular Psychiatry, 18, 3–4.
21. S.M.TomC.R.FoxC.TrepelR.A.Poldrack (2007). The neural basis of loss aversion in decision-making under risk. Science, 315, 515–518.
22. Y.-K.TuV.BælumM.S.Gilthorpe (2005). The relationship between baseline value and its change: Problems in categorization and the proposal of a new method. European Journal of Oral Sciences, 113, 279–288.
23. Y.-K.TuM.S.Gilthorpe (2007). Revisiting the relation between change and initial value: A review and evaluation. Statistics in Medicine, 26, 443–457.
24. A.TverskyD.Kahneman (1992). Advances in prospect theory: Cumulative representation of uncertainty. Journal of Risk and Uncertainty, 5, 297–323. doi:10.1007/BF00122574
25. P.WoodsM.Robinson (1981). An investigation of the comparative liposolubilities of beta-adrenoceptor blocking agents. Journal of Pharmacy and Pharmacology, 33, 172–173.